Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 25 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 9283256

    Antibacterial composition comprising Salvia extracts

    Botanic Century (Beijing) Co. Ltd. · Granted Mar 15, 2016 · Expires Mar 10, 2036

    granted
  2. US 9271949

    Compositions comprising acidic extracts of mastic gum

    REGENERA PHARMA LTD. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  3. US 9261507

    Anti CEACAM1 antibodies and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  4. US 9238838

    Microrna patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  5. US 9233927

    Crystals of laquinimod sodium and improved process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  6. US 9234179

    Materials and methods for generating pluripotent stem cells

    SHANGHAI UNITED STEM CELL BIOTECHNOLOGY CO., LTD. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  7. US 9226881

    Multi-functional composite powder

    JGC Catalysts and Chemicals Ltd. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  8. US 9220676

    Injectable in-situ crosslinked hydrogel and methods of making and using thereof

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  9. US 9220737

    Plant cell culture expressing human lysosomal proteins and uses thereof

    Protalix Ltd. · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  10. US 9198926

    Methods and compositions comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  11. US 9194011

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  12. US 9186333

    Process for preparing pharmaceutical compositions of fingolimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  13. US 9181277

    Aminoquinazoline derivatives and their salts and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  14. US 9180097

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  15. US 9180152

    Method for treating psoriasis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted
  16. US 9174411

    Laminated sheet and process for producing the same

    KURARAY KURAFLEX CO., LTD. · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted
  17. US 9174973

    Crystalline forms of azilsartan and preparation and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted
  18. US 9167841

    Tangerine peel extract and its preparation and application

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted
  19. US 9161936

    Laquinimod for treatment of GABA mediated disorders

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  20. US 9161935

    Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  21. US 9155775

    Process for manufacturing glatiramer acetate product

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted
  22. US 9133162

    Substituted quinoline compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted
  23. US 9125822

    Particle for medical use and process for producing the same

    SUMITOMO BAKELITE CO., LTD. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  24. US 9120872

    Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same

    REGENTIS BIOMATERIALS LTD. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted